Cabaletta Bio Appoints Global Commercial Leader Shawn Tomasello to Board of Directors
– Ms. Tomasello created and led global commercial and medical affairs functions at Kite Pharma…
– Ms. Tomasello created and led global commercial and medical affairs functions at Kite Pharma…
– Ms. Tomasello created and led global commercial and medical affairs functions at Kite Pharma…
BEDFORD, Mass., July 24, 2023 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused…
BEDFORD, Mass., July 24, 2023 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused…
REDWOOD CITY, Calif., July 24, 2023 (GLOBE NEWSWIRE) — Talis Biomedical Corporation (Nasdaq: TLIS), a…
REDWOOD CITY, Calif., July 24, 2023 (GLOBE NEWSWIRE) — Talis Biomedical Corporation (Nasdaq: TLIS), a…
The study’s primary endpoint was reached and demonstrated statistically significant and clinically meaningful results These…
The study’s primary endpoint was reached and demonstrated statistically significant and clinically meaningful results These…
Venlo, The Netherlands, July 24, 2023 (GLOBE NEWSWIRE) — QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock…
Venlo, The Netherlands, July 24, 2023 (GLOBE NEWSWIRE) — QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock…
Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Regain Compliance with NASDAQ Minimum Bid Price Requirement…
Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Regain Compliance with NASDAQ Minimum Bid Price Requirement…
BOSTON and SHANGHAI, China and LAUSANNE, Switzerland, July 24, 2023 (GLOBE NEWSWIRE) — Overland ADCT…
BOSTON and SHANGHAI, China and LAUSANNE, Switzerland, July 24, 2023 (GLOBE NEWSWIRE) — Overland ADCT…
BOSTON, July 24, 2023 (GLOBE NEWSWIRE) — Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology…
BOSTON, July 24, 2023 (GLOBE NEWSWIRE) — Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology…
STAMFORD, Conn., July 24, 2023 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical…
STAMFORD, Conn., July 24, 2023 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical…
SAN FRANCISCO, July 24, 2023 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ: FGEN) will announce its…
SAN FRANCISCO, July 24, 2023 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ: FGEN) will announce its…